When the Breakthrough Obesity G-Agonist Drugs Exceed Expectations The expanding GLP-1 family of drugs and their expanded potential use cases Back last December I wrote about the The New Obesity Breakthrough Drugs, and specifically the striking results in randomized trials for semaglutide (Wegovy) and tirzepatide (Mounjaro) for weight loss, their putative mechanism(s), while also emphasizing their very high cost, lack of plan for successful weaning, and exacerbation of health inequities
If you juggle multiple devices, bookmark your access page and avoid public WiFi for financial steps
While the side effects of these medications are sometimes talked about among those on GLP-1s, it doesn't make them normal
Testosterone is a critical hormone in mens health, influencing everything from muscle mass and energy levels to mood and metabolism
When using Ozempic for weight loss purposes, its possible that your body may adjust to the drug and plateau after a certain point
More intense immediate pain than usual